Rutgers and RWJBarnabas Health have unveiled plans for a $750 million Cancer Pavilion in New Brunswick that they say would allow scientists and doctors to turn the latest research into treatment under one roof. The partners said they hope the new center will become a model for cancer care.

The announcement of the project comes nearly a year after the public-private partnership began between the state’s largest health care system and Rutgers University. The Rutgers Cancer Institute is the only one in New Jersey designed as a national cancer institute, and one of 70 across the country.

“The Cancer Pavilion will be a model for cancer care delivery on the East Coast, bringing together the three mission areas of academic medicine — research, education and patient care – all under one roof,” said Barry H. Ostrowsky, CEO and president of RWJBarnabas.

The project will take about four years to complete, with work starting in summer 2020.

Though the exact location is still being finalized, the property is expected to be adjacent to the Robert Wood Johnson University Hospital and Rutgers Cancer Institute of New Jersey campus in New Brunswick.

"The final funding plan is still in development, and it is anticipated that philanthropy will play a significant role," said Ellen L. Greene, RWJBarnabas' vice president of public relations.

More:Does Rutgers' method for funding student-run paper violate First Amendment rights?

More:Rutgers University lecturers got a 'revolutionary' contract. Now some want it scrapped

The project is also a partnership with the New Brunswick Development Corporation, a private nonprofit urban real estate development company.

The Cancer Pavilion will house key outpatient services, including those for chemotherapy and radiation therapy, major diagnostic modalities and inpatient cancer services.

Plans also include research laboratories, which will enable physicians and scientists to quickly translate “scientific findings from laboratory bench to patient bedside, resulting in clinical assessment, feedback on clinical trials and collection of research data in a more rapid and direct fashion,” said a statement issued by the collaborators.

“By providing inpatient care in conjunction with world-class treatment and unique patient amenities all in one footprint, we are enhancing the level of care for the patients we serve in New Jersey and beyond,” said Rutgers Cancer Institute Director Steven K. Libutti.

Last year, RWJBarnabas announced it would invest more than $1 billion in Rutgers University for medical research and education over the next 20 years to create a new statewide academic health care system.

Email: carrera@northjersey.com